Lord, Abbett & Co’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-139,618
Closed -$23.6M 603
2023
Q3
$23.6M Sell
139,618
-434,988
-76% -$73.6M 0.09% 300
2023
Q2
$125M Buy
574,606
+83,464
+17% +$18.1M 0.43% 56
2023
Q1
$89.2M Sell
491,142
-57,179
-10% -$10.4M 0.32% 88
2022
Q4
$108M Sell
548,321
-146,457
-21% -$28.8M 0.39% 69
2022
Q3
$156M Buy
694,778
+412,548
+146% +$92.8M 0.57% 39
2022
Q2
$35.7M Sell
282,230
-87,315
-24% -$11M 0.13% 222
2022
Q1
$46.9M Buy
369,545
+127,840
+53% +$16.2M 0.12% 231
2021
Q4
$31.7M Sell
241,705
-69,911
-22% -$9.16M 0.07% 329
2021
Q3
$38.1M Sell
311,616
-57,030
-15% -$6.98M 0.09% 323
2021
Q2
$42M Buy
368,646
+55,085
+18% +$6.28M 0.1% 287
2021
Q1
$37.7M Buy
313,561
+37,834
+14% +$4.55M 0.1% 310
2020
Q4
$28M Buy
275,727
+6,648
+2% +$675K 0.07% 360
2020
Q3
$20.8M Buy
269,079
+7,535
+3% +$583K 0.07% 372
2020
Q2
$29.2M Sell
261,544
-52,031
-17% -$5.8M 0.1% 305
2020
Q1
$22.6M Buy
313,575
+120,612
+63% +$8.68M 0.1% 302
2019
Q4
$14.5M Buy
+192,963
New +$14.5M 0.05% 451